Showing results (51-60 of 106) with videos related to
Sort By:
Pageof 11
Research and Practice in Thrombosis and Haemostasis|October 24, 2018
Comparison of antithrombin-dependent and direct inhibitors of factor Xa or thrombin on the kinetics and qualitative characteristics of blood clotsStella Salta, Loula Papageorgiou, Annette K Larsen, et al.American Journal of Hematology|April 14, 2020
Hematological findings and complications of COVID-19Evangelos Terpos, Ioannis Ntanasis-Stathopoulos, Ismail Elalamy, et al.Thrombosis Research|October 8, 2013
Lobectomy and postoperative thromboprophylaxis with enoxaparin improve blood hypercoagulability in patients with localized primary lung adenocarcinomaChrysoula Papageorgiou, Patrick Vandreden, Emmanuel Marret, et al.International Journal of Hematology|August 21, 2010
Antiplatelet effect of once- or twice-daily aspirin dosage in stable coronary artery disease patients with diabetesFaouzi Addad, Tahar Chakroun, Ismail Elalamy, et al.Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|February 8, 2012
Description of response to aspirin and clopidogrel in outpatients with coronary artery disease using multiple electrode impedance aggregometryGrigoris T Gerotziafas, John Zarifis, Anastasia Bandi, et al.Genetic Testing and Molecular Biomarkers|March 26, 2011
The cyclooxygenase-1 C50T polymorphism is not associated with aspirin responsiveness status in stable coronary artery disease in Tunisian patientsTahar Chakroun, Faouzi Addad, Saloua Yacoub, et al.British Journal of Haematology|October 9, 2003
Pregnancy-associated venous thromboembolism (VTE) in combined heterozygous factor V Leiden (FVL) and prothrombin (FII) 20210 A mutation and in heterozygous FII single gene mutation aloneMeyer-Michel Samama, Roberto A Rached, Marie-Hélène Horellou, et al.The Oncologist|May 28, 2017
A Predictive Score for Thrombosis Associated with Breast, Colorectal, Lung, or Ovarian Cancer: The Prospective COMPASS-Cancer-Associated Thrombosis StudyGrigoris T Gerotziafas, Ali Taher, Hikmat Abdel-Razeq, et al.Thrombosis Research|May 5, 2009
Risk factors for unfavorable clinical outcome in patients with documented heparin-induced thrombocytopeniaIsmail Elalamy, Brigitte Tardy-Poncet, Agnès Mulot, et al.Journal of Thrombosis and Thrombolysis|April 22, 2009
Response variability to aspirin and one-year prediction of vascular events in patients with stable coronary artery diseaseFaouzi Addad, Tahar Chakroun, Fatma Abderazek, et al.Pageof 11